In gastric cancer patients, HMMR over-production was remarkably associated with tumor relapse and poor prognosis, and resulted in resistance to the chemotherapy via promoting epithelial-mesenchymal transition and modulating cancer stem cell properties (Zhang et al., 2019b). The gene discussed is HMMR; the disease is gastric cancer.